Report Thumbnail
Product Code LP0914910477UJ
Published Date 2023/2/24
English107 PagesGlobal

Global Neurorehabilitation Robotic Market Growth 2023-2029MedicalDevice_MedTech Market


Report Thumbnail
Product Code LP0914910477UJ◆The Feb 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2023/2/24
English 107 PagesGlobal

Global Neurorehabilitation Robotic Market Growth 2023-2029MedicalDevice_MedTech Market



Abstract


Summary

Robotic devices can replicate regimens designed by therapists and administer them as many times and for as long as they are needed. They can provide interactive training that is adjusted over time. From high-intensity sessions to task-specific and goal-oriented training, rehabilitation robots offer versatile and adaptive regimens.
LPI (LP Information)' newest research report, the “Neurorehabilitation Robotic Industry Forecast” looks at past sales and reviews total world Neurorehabilitation Robotic sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurorehabilitation Robotic sales for 2023 through 2029. With Neurorehabilitation Robotic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurorehabilitation Robotic industry.
This Insight Report provides a comprehensive analysis of the global Neurorehabilitation Robotic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurorehabilitation Robotic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Neurorehabilitation Robotic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurorehabilitation Robotic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurorehabilitation Robotic.
The global Neurorehabilitation Robotic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Neurorehabilitation Robotic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Neurorehabilitation Robotic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Neurorehabilitation Robotic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Neurorehabilitation Robotic players cover Ekso Bionics, Gloreha, Neurorehabilitation Robotics, Shanghai Siyi intelligent Technology, Cyberdyne, Bioventus, BIONIK Labs, Fourier Intelligence and Hocoma AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurorehabilitation Robotic market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Lower Extremities
Upper Extremities
Segmentation by application
Rehabilitation Centers
Hospitals and Clinics
Home Care
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ekso Bionics
Gloreha
Neurorehabilitation Robotics
Shanghai Siyi intelligent Technology
Cyberdyne
Bioventus
BIONIK Labs
Fourier Intelligence
Hocoma AG
Indego Exoskeleton
Myomo
Neofect
ReWalk Robotics
Key Questions Addressed in this Report
What is the 10-year outlook for the global Neurorehabilitation Robotic market?
What factors are driving Neurorehabilitation Robotic market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurorehabilitation Robotic market opportunities vary by end market size?
How does Neurorehabilitation Robotic break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Neurorehabilitation Robotic Annual Sales 2018-2029
      • 2.1.2 World Current & Future Analysis for Neurorehabilitation Robotic by Geographic Region, 2018, 2022 & 2029
      • 2.1.3 World Current & Future Analysis for Neurorehabilitation Robotic by Country/Region, 2018, 2022 & 2029
    • 2.2 Neurorehabilitation Robotic Segment by Type
      • 2.2.1 Lower Extremities
      • 2.2.2 Upper Extremities
    • 2.3 Neurorehabilitation Robotic Sales by Type
      • 2.3.1 Global Neurorehabilitation Robotic Sales Market Share by Type (2018-2023)
      • 2.3.2 Global Neurorehabilitation Robotic Revenue and Market Share by Type (2018-2023)
      • 2.3.3 Global Neurorehabilitation Robotic Sale Price by Type (2018-2023)
    • 2.4 Neurorehabilitation Robotic Segment by Application
      • 2.4.1 Rehabilitation Centers
      • 2.4.2 Hospitals and Clinics
      • 2.4.3 Home Care
      • 2.4.4 Others
    • 2.5 Neurorehabilitation Robotic Sales by Application
      • 2.5.1 Global Neurorehabilitation Robotic Sale Market Share by Application (2018-2023)
      • 2.5.2 Global Neurorehabilitation Robotic Revenue and Market Share by Application (2018-2023)
      • 2.5.3 Global Neurorehabilitation Robotic Sale Price by Application (2018-2023)
  • 3 Global Neurorehabilitation Robotic by Company

    • 3.1 Global Neurorehabilitation Robotic Breakdown Data by Company
      • 3.1.1 Global Neurorehabilitation Robotic Annual Sales by Company (2018-2023)
      • 3.1.2 Global Neurorehabilitation Robotic Sales Market Share by Company (2018-2023)
    • 3.2 Global Neurorehabilitation Robotic Annual Revenue by Company (2018-2023)
      • 3.2.1 Global Neurorehabilitation Robotic Revenue by Company (2018-2023)
      • 3.2.2 Global Neurorehabilitation Robotic Revenue Market Share by Company (2018-2023)
    • 3.3 Global Neurorehabilitation Robotic Sale Price by Company
    • 3.4 Key Manufacturers Neurorehabilitation Robotic Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Neurorehabilitation Robotic Product Location Distribution
      • 3.4.2 Players Neurorehabilitation Robotic Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    • 3.6 New Products and Potential Entrants
    • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Neurorehabilitation Robotic by Geographic Region

    • 4.1 World Historic Neurorehabilitation Robotic Market Size by Geographic Region (2018-2023)
      • 4.1.1 Global Neurorehabilitation Robotic Annual Sales by Geographic Region (2018-2023)
      • 4.1.2 Global Neurorehabilitation Robotic Annual Revenue by Geographic Region (2018-2023)
    • 4.2 World Historic Neurorehabilitation Robotic Market Size by Country/Region (2018-2023)
      • 4.2.1 Global Neurorehabilitation Robotic Annual Sales by Country/Region (2018-2023)
      • 4.2.2 Global Neurorehabilitation Robotic Annual Revenue by Country/Region (2018-2023)
    • 4.3 Americas Neurorehabilitation Robotic Sales Growth
    • 4.4 APAC Neurorehabilitation Robotic Sales Growth
    • 4.5 Europe Neurorehabilitation Robotic Sales Growth
    • 4.6 Middle East & Africa Neurorehabilitation Robotic Sales Growth
  • 5 Americas

    • 5.1 Americas Neurorehabilitation Robotic Sales by Country
      • 5.1.1 Americas Neurorehabilitation Robotic Sales by Country (2018-2023)
      • 5.1.2 Americas Neurorehabilitation Robotic Revenue by Country (2018-2023)
    • 5.2 Americas Neurorehabilitation Robotic Sales by Type
    • 5.3 Americas Neurorehabilitation Robotic Sales by Application
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Neurorehabilitation Robotic Sales by Region
      • 6.1.1 APAC Neurorehabilitation Robotic Sales by Region (2018-2023)
      • 6.1.2 APAC Neurorehabilitation Robotic Revenue by Region (2018-2023)
    • 6.2 APAC Neurorehabilitation Robotic Sales by Type
    • 6.3 APAC Neurorehabilitation Robotic Sales by Application
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Neurorehabilitation Robotic by Country
      • 7.1.1 Europe Neurorehabilitation Robotic Sales by Country (2018-2023)
      • 7.1.2 Europe Neurorehabilitation Robotic Revenue by Country (2018-2023)
    • 7.2 Europe Neurorehabilitation Robotic Sales by Type
    • 7.3 Europe Neurorehabilitation Robotic Sales by Application
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Neurorehabilitation Robotic by Country
      • 8.1.1 Middle East & Africa Neurorehabilitation Robotic Sales by Country (2018-2023)
      • 8.1.2 Middle East & Africa Neurorehabilitation Robotic Revenue by Country (2018-2023)
    • 8.2 Middle East & Africa Neurorehabilitation Robotic Sales by Type
    • 8.3 Middle East & Africa Neurorehabilitation Robotic Sales by Application
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Neurorehabilitation Robotic
    • 10.3 Manufacturing Process Analysis of Neurorehabilitation Robotic
    • 10.4 Industry Chain Structure of Neurorehabilitation Robotic
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Neurorehabilitation Robotic Distributors
    • 11.3 Neurorehabilitation Robotic Customer
  • 12 World Forecast Review for Neurorehabilitation Robotic by Geographic Region

    • 12.1 Global Neurorehabilitation Robotic Market Size Forecast by Region
      • 12.1.1 Global Neurorehabilitation Robotic Forecast by Region (2024-2029)
      • 12.1.2 Global Neurorehabilitation Robotic Annual Revenue Forecast by Region (2024-2029)
    • 12.2 Americas Forecast by Country
    • 12.3 APAC Forecast by Region
    • 12.4 Europe Forecast by Country
    • 12.5 Middle East & Africa Forecast by Country
    • 12.6 Global Neurorehabilitation Robotic Forecast by Type
    • 12.7 Global Neurorehabilitation Robotic Forecast by Application
  • 13 Key Players Analysis

    • 13.1 Ekso Bionics
      • 13.1.1 Ekso Bionics Company Information
      • 13.1.2 Ekso Bionics Neurorehabilitation Robotic Product Portfolios and Specifications
      • 13.1.3 Ekso Bionics Neurorehabilitation Robotic Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.1.4 Ekso Bionics Main Business Overview
      • 13.1.5 Ekso Bionics Latest Developments
    • 13.2 Gloreha
      • 13.2.1 Gloreha Company Information
      • 13.2.2 Gloreha Neurorehabilitation Robotic Product Portfolios and Specifications
      • 13.2.3 Gloreha Neurorehabilitation Robotic Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.2.4 Gloreha Main Business Overview
      • 13.2.5 Gloreha Latest Developments
    • 13.3 Neurorehabilitation Robotics
      • 13.3.1 Neurorehabilitation Robotics Company Information
      • 13.3.2 Neurorehabilitation Robotics Neurorehabilitation Robotic Product Portfolios and Specifications
      • 13.3.3 Neurorehabilitation Robotics Neurorehabilitation Robotic Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.3.4 Neurorehabilitation Robotics Main Business Overview
      • 13.3.5 Neurorehabilitation Robotics Latest Developments
    • 13.4 Shanghai Siyi intelligent Technology
      • 13.4.1 Shanghai Siyi intelligent Technology Company Information
      • 13.4.2 Shanghai Siyi intelligent Technology Neurorehabilitation Robotic Product Portfolios and Specifications
      • 13.4.3 Shanghai Siyi intelligent Technology Neurorehabilitation Robotic Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.4.4 Shanghai Siyi intelligent Technology Main Business Overview
      • 13.4.5 Shanghai Siyi intelligent Technology Latest Developments
    • 13.5 Cyberdyne
      • 13.5.1 Cyberdyne Company Information
      • 13.5.2 Cyberdyne Neurorehabilitation Robotic Product Portfolios and Specifications
      • 13.5.3 Cyberdyne Neurorehabilitation Robotic Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.5.4 Cyberdyne Main Business Overview
      • 13.5.5 Cyberdyne Latest Developments
    • 13.6 Bioventus
      • 13.6.1 Bioventus Company Information
      • 13.6.2 Bioventus Neurorehabilitation Robotic Product Portfolios and Specifications
      • 13.6.3 Bioventus Neurorehabilitation Robotic Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.6.4 Bioventus Main Business Overview
      • 13.6.5 Bioventus Latest Developments
    • 13.7 BIONIK Labs
      • 13.7.1 BIONIK Labs Company Information
      • 13.7.2 BIONIK Labs Neurorehabilitation Robotic Product Portfolios and Specifications
      • 13.7.3 BIONIK Labs Neurorehabilitation Robotic Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.7.4 BIONIK Labs Main Business Overview
      • 13.7.5 BIONIK Labs Latest Developments
    • 13.8 Fourier Intelligence
      • 13.8.1 Fourier Intelligence Company Information
      • 13.8.2 Fourier Intelligence Neurorehabilitation Robotic Product Portfolios and Specifications
      • 13.8.3 Fourier Intelligence Neurorehabilitation Robotic Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.8.4 Fourier Intelligence Main Business Overview
      • 13.8.5 Fourier Intelligence Latest Developments
    • 13.9 Hocoma AG
      • 13.9.1 Hocoma AG Company Information
      • 13.9.2 Hocoma AG Neurorehabilitation Robotic Product Portfolios and Specifications
      • 13.9.3 Hocoma AG Neurorehabilitation Robotic Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.9.4 Hocoma AG Main Business Overview
      • 13.9.5 Hocoma AG Latest Developments
    • 13.10 Indego Exoskeleton
      • 13.10.1 Indego Exoskeleton Company Information
      • 13.10.2 Indego Exoskeleton Neurorehabilitation Robotic Product Portfolios and Specifications
      • 13.10.3 Indego Exoskeleton Neurorehabilitation Robotic Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.10.4 Indego Exoskeleton Main Business Overview
      • 13.10.5 Indego Exoskeleton Latest Developments
    • 13.11 Myomo
      • 13.11.1 Myomo Company Information
      • 13.11.2 Myomo Neurorehabilitation Robotic Product Portfolios and Specifications
      • 13.11.3 Myomo Neurorehabilitation Robotic Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.11.4 Myomo Main Business Overview
      • 13.11.5 Myomo Latest Developments
    • 13.12 Neofect
      • 13.12.1 Neofect Company Information
      • 13.12.2 Neofect Neurorehabilitation Robotic Product Portfolios and Specifications
      • 13.12.3 Neofect Neurorehabilitation Robotic Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.12.4 Neofect Main Business Overview
      • 13.12.5 Neofect Latest Developments
    • 13.13 ReWalk Robotics
      • 13.13.1 ReWalk Robotics Company Information
      • 13.13.2 ReWalk Robotics Neurorehabilitation Robotic Product Portfolios and Specifications
      • 13.13.3 ReWalk Robotics Neurorehabilitation Robotic Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.13.4 ReWalk Robotics Main Business Overview
      • 13.13.5 ReWalk Robotics Latest Developments
  • 14 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.
Global Neurorehabilitation Robotic Market Growth 2023-2029 | MedicalDevice_MedTech Market Research Report - ShareFair Markets